01—Abstract
Summary
Summary of the 10-K filed September 28, 2001. Cited figures are marked; the original filing is the authoritative source.
Archer-Daniels-Midland (ADM) reported fiscal 2001 (year ended June 30, 2001) net earnings of $383.3 milliona, or $0.58 per share, up roughly 27% from $300.9 million, or $0.45 per share, in fiscal 2000.
Net sales and other operating income rose 8% to $20.1 billionb, driven by higher average selling prices and volumes of grain merchandised. Gross profit increased to $1.43 billion from $1.22 billion, helped by strong demand for protein meal (tied to BSE-related meat and bone meal restrictions) and higher fuel alcohol sales, partly offset by significantly higher energy and fuel costs. The earnings gain was also aided by a $95 million equity share of a gain at affiliate CIP and by a lower effective tax rate of 27%, which excluded taxes on the CIP gain.
Management notes that excluding the CIP transaction and the prior-year $60 millionc tax credit, the effective tax rate was about 32%, so underlying profitability improved less dramatically than headline figures suggest. The balance sheet remains conservative. Working capital was $2.3 billion, shareholders' equity was $6.3 billion, and the ratio of long-term debt to total capital was about 32%.
Total assets fell slightly to $14.3 billiond, reflecting lower inventories and reduced short-term borrowings, which dropped from $1.55 billion to $876 million. ADM issued $400 million of 7% debentures due 2031. Cash flow from operations was $864 million, and capital spending on property, plant and equipment was reduced to $273 million from $429 million.
Shareholder returns continued through dividends of $0.19 per share and modest share repurchases. Investors should note ongoing legal and regulatory exposure.
ADM faces numerous antitrust suits and investigations involving high fructose corn syrup, lysine, citric acid, and monosodium glutamate in the U.S., Canada, Europe, Mexico, and Brazil, including a EUR 47.3 million European Commission fine on lysine that the company is appealing. Management states that none of these matters is expected to have a material adverse effect on the company's financial condition, though the ultimate outcomes cannot yet be determined.
02—Key points
Key Highlights
- Net earnings rose to $383.3 million ($0.58/share) from $300.9 million ($0.45/share), a 27% increase.
- Net sales and other operating income grew 8% to $20.1 billion, driven by higher selling prices and grain merchandising volumes.
- Gross profit increased $212 million to $1.43 billion, led by Oilseeds & Corn Processing on strong protein meal demand and fuel alcohol sales.
- Earnings were aided by a $95 million equity share of a gain at affiliate CIP and an effective tax rate of 27%; excluding these items, the underlying rate was about 32%.
- Balance sheet remains strong with $2.3 billion working capital, $6.3 billion shareholders' equity, and long-term debt at about 32% of total capital.
- Short-term debt fell to $876 million from $1.55 billion, and capital expenditures dropped to $273 million from $429 million.
- Ongoing antitrust exposure in HFCS, lysine, citric acid, and MSG matters across multiple jurisdictions; management does not expect a material adverse effect.
03—Questions
Frequently Asked Questions
How did ADM's earnings change in fiscal 2001 and what drove the improvement?
Net earnings rose 27% to $383.3 million, or $0.58 per share, from $300.9 million, or $0.45 per share. The improvement was driven by higher gross profit in Oilseeds & Corn Processing, where demand for protein meal increased after BSE-related meat and bone meal restrictions, and fuel alcohol sales grew. A $95 million equity gain at affiliate CIP and a lower tax rate also contributed.
Is the 27% effective tax rate in 2001 a sustainable level for investors to expect?
Probably not entirely. The 27% rate reflects no taxes on the CIP gain, which is permanently reinvested. Management said the underlying effective rate, excluding the CIP transaction and the prior-year $60 million credit, was about 32% in both 2001 and 2000. Investors should use the higher rate when projecting future earnings unless similar one-time items recur.
What are the most significant legal risks facing ADM?
ADM is a defendant in numerous antitrust suits and investigations covering high fructose corn syrup, lysine, citric acid, and monosodium glutamate in the U.S., Canada, Europe, Mexico, and Brazil. The European Commission fined the company EUR 47.3 million over lysine, which ADM is appealing. Management believes none of these matters will have a material adverse effect, but outcomes in the European and Brazilian proceedings cannot yet be determined.
How is ADM's financial position and liquidity?
The company remains financially strong. It had $2.3 billion in working capital, a current ratio of 1.6, and $2.1 billion in committed bank lines, of which $1.2 billion was unused. Long-term debt to total capital was about 32%. Short-term borrowings were reduced substantially during the year, and operating cash flow of $864 million covered investing needs and dividends.
What are the key drivers of ADM's revenue, and how sensitive is it to commodity prices?
Revenue is driven mainly by merchandising large volumes of agricultural commodities, with sales up 8% to $20.1 billion on higher average prices and volumes. Because raw materials are agricultural commodities subject to weather and policy swings, ADM hedges with exchange-traded futures. Its disclosed commodity market risk was modest, with the average net position estimated at a $5 million potential fair-value loss under a hypothetical 10% adverse price move.
04—Continue